Medline Inc. Class A Common Stock (MDLN) — Cash Flow Reinvestment Rate
Medline Inc. Class A Common Stock (MDLN) has a Cash Flow Reinvestment Rate of 0.23x as of March 2026, reinvesting $96.00 Million (capex $96.00 Million ) from operating cash flow of $412.00 Million. Explore MDLN capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Medline Inc. Class A Common Stock Cash Flow Reinvestment Rate (2022–2025)
Historical reinvestment intensity for Medline Inc. Class A Common Stock across 4 annual periods. Also explore Medline Inc. Class A Common Stock asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Medline Inc. Class A Common Stock (2022–2025)
Year-by-year capital reinvestment analysis for Medline Inc. Class A Common Stock. For live market cap and broader valuation context, see market value of Medline Inc. Class A Common Stock.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.26x | $447.00 Million | $1.74 Billion | $447.00 Million | ▲ +24.6% |
| 2024 | 0.21x | $364.00 Million | $1.77 Billion | $364.00 Million | ▲ +21.7% |
| 2023 | 0.17x | $285.00 Million | $1.69 Billion | $285.00 Million | ▼ -87.5% |
| 2022 | 1.36x | $254.00 Million | $187.00 Million | $254.00 Million | — |